Equinor ASA: Tilbakekjøp av egne aksjer
August 06, 2024 02:00 ET
|
Equinor ASA
Nedenfor følger informasjon om transaksjoner foretatt under tredje transje av Equinor ASAs (OSE:EQNR, NYSE:EQNR, CEUX:EQNRO, TQEX:EQNRO) tilbakekjøpsprogram for 2024. Dato for når tredje transje av...
Equinor ASA: Share buy-back
August 06, 2024 02:00 ET
|
Equinor ASA
Please see below information about transactions made under the third tranche of the 2024 share buy-back programme for Equinor ASA (OSE:EQNR, NYSE:EQNR, CEUX:EQNRO, TQEX:EQNRO). Date on which the...
BW Energy: Long-Term Incentive Program – new awards
August 06, 2024 01:30 ET
|
BW Energy Limited
BW Energy: Long-Term Incentive Program – new awards The Board of Directors of BW Energy Limited ("BWE" or the "Company") approved the award of share options under a Long-Term Incentive Program...
Q2 2024 Trading Update and Invitation to Earnings Call
August 06, 2024 01:00 ET
|
DNO ASA
Oslo, 6 August 2024 – DNO ASA, the Norwegian oil and gas operator, will publish its Q2 2024 operating and interim financial results on 15 August at 07:00 (CET). A videoconference call with executive...
Okeanis Eco Tankers Corp. – Invitation to Q2 2024 Results Conference Call and Webcast
August 05, 2024 16:10 ET
|
Okeanis Eco Tankers Corp
ATHENS, Greece, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Okeanis Eco Tankers Corp. (the “Company” or “OET”) (NYSE:ECO / OSE:OET), will report unaudited interim condensed results for the second quarter and...
Subsea 7 S.A. notification of major holding
August 05, 2024 14:59 ET
|
Subsea 7 (Uk Service Co) Ltd
Luxembourg – 5 August 2024 – Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced that, on 5 August 2024, Barclays Capital Securities Limited1 informed the Company that it had crossed...
Ultimovacs Announces Topline Data from FOCUS Phase II Trial of UV1 Combined with Pembrolizumab in Patients with Metastatic or Recurrent Head and Neck Cancer
August 05, 2024 13:12 ET
|
Ultimovacs ASA
Adding Ultimovacs’ cancer vaccine UV1 to checkpoint inhibitor pembrolizumab did not meet primary or secondary endpoints in patients with metastatic or recurrent head and neck squamous cell...
AKVA group ASA: Status buyback of own shares
August 05, 2024 10:58 ET
|
AKVA group ASA
As announced on 22 March 2024 AKVA group ASA ("AKVA group" or the "Company") has initiated repurchase of up to 200 000 of the company's own shares to be used in its share programme for employees. ...
Ensurge Micropower ASA - Registration of Share Capital Increase
August 05, 2024 10:45 ET
|
Ensurge Micropower ASA
Oslo, 5 August 2024 Reference is made to the announcement by Ensurge Micropower ASA (the "Company") on 25 July 2024 regarding conversion of a convertible loan in the amount of NOK 1,000,000...
Invitation to presentation of Scatec ASA’s second quarter results 2024
August 05, 2024 10:40 ET
|
Scatec ASA
Oslo, 5 August 2024: Scatec ASA will release its second quarter and first half results on Friday 16 August 2024 at 07:00 am (CEST). A presentation of the results followed by a Q&A session will be...